GGrantIndex
← Search

DEVELOPMENT OF A NOVEL CELL-BASED, LIVE INFLUENZA VACCINE WITH UNIVERSAL ATTRIBUTES

$4,198,890FY2019Department of the ArmyDOD

Flugen Inc

Investigators

View source on USAspending →
DEVELOPMENT OF A NOVEL CELL-BASED, LIVE INFLUENZA VACCINE WITH UNIVERSAL ATTRIBUTES · GrantIndex